Pub. Date : 2016 Dec
PMID : 27919974
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy. | Tegafur | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 2 | We evaluated the tolerability and safety of tegafur-uracil (UFT) as adjuvant chemotherapy for patients with human epidermal growth factor receptor 2-negative breast cancer that resulted in non-pCR after NAC. | Tegafur | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 3 | We evaluated the tolerability and safety of tegafur-uracil (UFT) as adjuvant chemotherapy for patients with human epidermal growth factor receptor 2-negative breast cancer that resulted in non-pCR after NAC. | Tegafur | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |